Home
About
FAQ
History (4)
Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States.
Evaluating Topical JAK Inhibitors as a Treatment Option for Atopic Dermatitis.
Posttraumatic Stress Disorder and Neurocognitive Impairment in a U.S. Military Cohort of Persons Living with HIV.
Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluating Topical JAK Inhibitors as a Treatment Option for Atopic Dermatitis.
Fardos MI, Singh R, Perche PO, Kelly KA, Feldman SR. Evaluating Topical JAK Inhibitors as a Treatment Option for Atopic Dermatitis. Expert Rev Clin Immunol. 2021 Oct 12.
View in:
PubMed
authors with profiles
Steven R. Feldman MD, PhD
Dalane W. Kitzman MD